Eugene Schneider
Chief Tech/Sci/R&D Officer en IONIS PHARMACEUTICALS, INC. .
Fortuna: 2 M $ al 31/03/2024
Perfil
En la actualidad, Eugene Schneider ocupa el cargo de Director de Desarrollo Clínico y Vicepresidente Ejecutivo de Ionis Pharmaceuticals, Inc. El Dr. Schneider es también Director Médico y Vicepresidente de Salud Mental en Excellus BlueCross BlueShield. En el pasado, el Dr. Schneider fue Director Médico Senior en Biovail Technologies Ltd. y Director Médico Senior en Synageva BioPharma Corp. Se doctoró en la Universidad de Medicina y Odontología de Nueva Jersey.
Participaciones conocidas en empresas públicas
Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
---|---|---|---|---|
02/02/2024 | 49 812 ( 0.03% ) | 2 M $ | 31/03/2024 |
Cargos activos de Eugene Schneider
Empresas | Cargo | Inicio |
---|---|---|
IONIS PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | - |
Excellus Health Plan, Inc.
Excellus Health Plan, Inc. Managed Health CareHealth Services Excellus Health Plan, Inc. provides health care and long term care insurance plans for individuals and families, sole proprietors, small businesses, and midsize and large businesses in New York. The company is headquartered in New York, NY. | Chief Tech/Sci/R&D Officer | - |
Antiguos cargos conocidos de Eugene Schneider.
Empresas | Cargo | Fin |
---|---|---|
Biovail Technologies Ltd. | Chief Tech/Sci/R&D Officer | - |
SYNAGEVA BIOPHARMA CORP | Chief Tech/Sci/R&D Officer | - |
Formación de Eugene Schneider.
University of Medicine & Dentistry of New Jersey | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
IONIS PHARMACEUTICALS, INC. | Health Technology |
Empresas privadas | 3 |
---|---|
Excellus Health Plan, Inc.
Excellus Health Plan, Inc. Managed Health CareHealth Services Excellus Health Plan, Inc. provides health care and long term care insurance plans for individuals and families, sole proprietors, small businesses, and midsize and large businesses in New York. The company is headquartered in New York, NY. | Health Services |
Biovail Technologies Ltd. | |
Synageva BioPharma Corp.
Synageva BioPharma Corp. BiotechnologyHealth Technology Synageva BioPharma Corp. is a biopharmaceutical company which focuses on the discovery, development, and commercialization of therapeutic products for patients with life-threatening rare diseases and high unmet medical need. The company is currently evaluating sebelipase alfa in global clinical trials for LAL Deficiency, a lysosomal storage disease associated with liver damage and accelerated atherosclerosis in children and adults, and in infants, premature death often before six months of age. Synageva BioPharma was founded in 1993 and is headquartered in Lexington, MA. | Health Technology |
- Bolsa de valores
- Insiders
- Eugene Schneider